These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3216505)

  • 21. Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils.
    Matsunaga Y; Kido H; Kawaji K; Kamoshita K; Katunuma N; Ogura T
    Arch Biochem Biophys; 1994 Jul; 312(1):67-74. PubMed ID: 8031148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of lacto-N-fucopentaose III (CD15)- and sialyl-Lewis X-bearing molecules and their functional properties in eosinophils from patients with the idiopathic hypereosinophilic syndrome.
    Satoh T; Knowles A; Li MS; Sun L; Tooze JA; Zabucchi G; Spry CJ
    Immunology; 1994 Oct; 83(2):313-8. PubMed ID: 7835953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhibition of eosinophil peroxidase release by chymotrypsin type protease inhibitors from activated human eosinophils].
    Kawaji K; Matsunaga Y; Kido H; Ogura T
    Arerugi; 1993 Oct; 42(10):1591-9. PubMed ID: 8250722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effectiveness of measuring for fragmented red cells using an automated hematology analyzer in patients with thrombotic microangiopathy.
    Abe Y; Wada H; Yamada E; Noda M; Ikejiri M; Nishioka J; Kobayashi T; Matsumoto T; Masuya M; Isaji S; Usui M; Uemoto S; Katayama N; Nobori T
    Clin Appl Thromb Hemost; 2009; 15(3):257-62. PubMed ID: 18603539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Giant neutrophils with increased peroxidase activity. Another evidence of dysgranulopoiesis in AIDS.
    d'Onofrio G; Mancini S; Tamburrini E; Mango G; Ortona L
    Am J Clin Pathol; 1987 May; 87(5):584-91. PubMed ID: 3034051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eleven cases with lowered eosinophil peroxidase activity.
    Takubo T
    Eur J Haematol; 1989 Jul; 43(1):80. PubMed ID: 2548893
    [No Abstract]   [Full Text] [Related]  

  • 27. Human eosinophil peroxidase: a novel isolation procedure, spectral properties and chlorinating activity.
    Wever R; Plat H; Hamers MN
    FEBS Lett; 1981 Jan; 123(2):327-31. PubMed ID: 6262111
    [No Abstract]   [Full Text] [Related]  

  • 28. Characterization of the peroxidase in human eosinophils.
    Wever R; Hamers MN; de Graaf CJ; Weening RS; Roos D
    Adv Exp Med Biol; 1982; 141():501-9. PubMed ID: 7090924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of an automated hematology analyzer and flow cytometry to assess bone marrow cellularity and differential cell count.
    Kim M; Kim J; Lim J; Kim Y; Han K; Kang CS
    Ann Clin Lab Sci; 2004; 34(3):307-13. PubMed ID: 15487705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of hematopoietic progenitor cell count determined by the SE-automated hematology analyzer with CD34(+) cell count by flow cytometry in leukapheresis products.
    Park KU; Kim SH; Suh C; Kim S; Lee SJ; Park JS; Cho HJ; Kim KW; Lee K; Kim HJ; Park J; Joo Min Y; Kim JG; Kim T; Lee JH; Kim SB; Kim SW; Lee KH; Lee JS; Kim WK; Park CJ; Chi HS
    Am J Hematol; 2001 May; 67(1):42-7. PubMed ID: 11279656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet-activating factor induces eosinophil peroxidase release from purified human eosinophils.
    Kroegel C; Yukawa T; Dent G; Chanez P; Chung KF; Barnes PJ
    Immunology; 1988 Jul; 64(3):559-61. PubMed ID: 3410498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel technique for the direct flow cytofluorometric analysis of human basophils in unseparated blood and bone marrow, and the characterization of phenotype and peroxidase of human basophils.
    Toba K; Koike T; Shibata A; Hashimoto S; Takahashi M; Masuko M; Azegami T; Takahashi H; Aizawa Y
    Cytometry; 1999 Mar; 35(3):249-59. PubMed ID: 10082306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal.
    Lönnkvist K; Hellman C; Lundahl J; Halldén G; Hedlin G
    J Allergy Clin Immunol; 2001 May; 107(5):812-7. PubMed ID: 11344347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Change of the activity of leukocyte peroxidase in bronchial asthma].
    Rudyk BI
    Vrach Delo; 1975 Aug; (8):65-7. PubMed ID: 1221611
    [No Abstract]   [Full Text] [Related]  

  • 35. Fully automated cytochemistry on whole blood smears using the Technicon Hemalog D or Technicon H6000/Autoslide: myeloperoxidase staining methods.
    Lippi U; Cappelletti P; Schinella M
    Nouv Rev Fr Hematol (1978); 1987; 29(5):321-5. PubMed ID: 2830589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The localization of peroxidase and acid phosphatase in eosinophil leukocytes during maturation. Electron microscopical cytochemical studies on the bone marrow of the rat and rabbit].
    Miller F; Herzog V
    Z Zellforsch Mikrosk Anat; 1969; 97(1):84-110. PubMed ID: 4895257
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of haemoglobin on the Technicon H6000 eosinophil count.
    Reardon DM; Hewitt J
    Clin Lab Haematol; 1986; 8(4):369-70. PubMed ID: 3791889
    [No Abstract]   [Full Text] [Related]  

  • 38. Occult deposition of eosinophil peroxidase in a subset of human breast carcinomas.
    Samoszuk MK; Nguyen V; Gluzman I; Pham JH
    Am J Pathol; 1996 Mar; 148(3):701-6. PubMed ID: 8774125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human eosinophil peroxidase: purification and characterization.
    Carlson MG; Peterson CG; Venge P
    J Immunol; 1985 Mar; 134(3):1875-9. PubMed ID: 3918110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of eosinophil peroxidase deficiency.
    Kutter D; Mueller-Hagedorn S; Forges T; Glaesener R
    Ann Hematol; 1995 Dec; 71(6):315-7. PubMed ID: 8534766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.